Breast & Cervical Cancer QI Module

Note: Due to changes at the ABFM, the OAFP will sunset its modules at the end of 2018. Check back in early 2019 for the launch of a new initiative.

As a free benefit of membership, the Ohio Academy of Family Physicians has created the Breast & Cervical Cancer Quality Improvement (QI) Module to assist members and their practice teams in improving the care women receive related to the prevention and early detection of breast and cervical cancer.

The module has been approved by the American Board of Family Medicine (ABFM) as an alternative Family Medicine Certification Performance Improvement (PI) activity for 20 PI points and by the American Academy of Family Physicians for 20 continuing medical education credits.

Aligned with U.S. Preventive Services Task Force guidelines for breast and cervical screenings, module participants will begin by choosing to focus on a specific age group—either young women (between the ages of 21 and 26) for HPV immunization and appropriate pap testing, or middle-aged women (between 50 and 65) for appropriate pap testing and mammography screening. Then, participants will be guided through three phases:
  • A pre-assessment phase to evaluate the current practice’s care delivery and selection of a plan for improvement using a Plan, Do, Study, Act (PDSA) cycle
  • An action phase for the practice to implement its plan for improvement for a minimum of three months
  • A post-assessment phase to analyze data, reflect on successes and challenges incurred, and evaluate the program.

For an overview on completing the module, watch the video below.

“By completing this module, I had the opportunity to inform and educate my patients on the current guidelines for cancer screening. This allowed my patients to make informed decisions about their own health care choices,” stated a module participant.


Once the module has been completed, the OAFP will report final credit of the participating member physician to the AAFP and the ABFM. View the module tutorial video for a detailed explanation on completing the module.

If you have questions regarding this module, please contact Director of Performance Improvement Erin Jech or call 800.742.7327.

Resources, References, and Tools for Completing the Module

Within the module, once you complete your practice assessment and chart review, you will focus on a practice improvement strategy. Below are pathways within the module that you can choose from to improve the care of female patients. Within each pathway are several interventions. To complete this module, you will need to select one intervention to implement into practice.

Cancer Prevention: Women age 21 – 26 years old
Cancer Screening: Women age 50 – 65 years old

Accreditation Statement

This activity has been approved by the ABFM for Performance Improvement credit toward Family Medicine Certification Requirements. Term of approval is for two years that began January 1, 2018, with the option for yearly renewal thereafter. Please note that once an activity is started, it must be completed within one calendar year. If the activity is not completed in that time, the activity must be restarted. In addition, for the alternate Performance Improvement activity to apply toward the Family Medicine Certification requirement, it must be completed in the stage the Diplomate wishes to receive the credit. To fully implement your practice improvement plan and analyze your results, it will take you a minimum of three months to complete the process. Please plan accordingly.

Although there is no cost to utilize this module, ABFM Diplomates who complete alternate Performance Improvement activities must submit the required Family Medicine Certification fees to the ABFM in order to receive credit for the alternate activity.

This Performance Improvement in Practice activity, Breast & Cervical Cancer QI Program, has been reviewed and is acceptable for up to 20.00 Prescribed credit(s) by the American Academy of Family Physicians. Term of approval began January 1, 2018. Term of approval is for two years from this date.

Once the module has been completed, the OAFP will report final credit of the participating member physician to the AAFP and the ABFM so long as the physician’s ABFM and AAFP member numbers were accurately submitted in the profile record. Participants who successfully complete the module, including submitting the evaluation, will have a statement of credit made available immediately.

Learning Objectives

  1. Describe the importance of practice team engagement on improving cancer prevention and screening rates among female patients
  2. Determine the gaps in the breast and cervical screening that is currently being provided to female patients
  3. Implement interventions in practice to ensure appropriate breast and cervical screening in female patients
  4. Identify strategies to discuss appropriate cancer screenings with their female patients
  5. Demonstrate improvement in preventive care in female patients as a result of systems changes identified through QI initiatives.

Statement of Need

According to the American Cancer Society, it is estimated that in 2018, approximately 13,240 new cases of invasive cervical cancer will be diagnosed and 4,170 women will die of the disease. The National Cancer Institute reports that in 2017, it was estimated that there would be 252,710 new cases of breast cancer and an estimated 40,610 deaths from the disease.

Fortunately, the Affordable Care Act will increase access to screening for cervical and breast cancers, especially for underserved and low income women, according to the CDC. As the United States struggles to bring health care costs under control, it is important for physicians to know and incorporate into practice, the latest guidelines regarding screening for cervical and breast cancers.


  • Ryan Kauffman, MD, (Project Champion)
  • Theresa Barrett, PhD, CMP, CAE
  • Kenneth Bertka, MD
  • Heidi Gullett, MD, MPH
  • Douglas Harley, DO
  • Gary LeRoy, MD


  • Alexandria Howard, MD
  • Erin Jech
  • Mary Krebs, MD
  • Kate Mahler, CAE
  • Terry Wagner, DO
  • Cynthia Weinstein, MD
  • Steve Zitelli, MD

Faculty Disclosure

The OAFP adheres to the conflict-of-interest policy of the AAFP as well as to the guidelines of the Accreditation Council for Continuing Medical Education and the American Medical Association. Current guidelines state that participants in continuing medical education activities should be made aware of any affiliation or financial interest that may affect an author’s article.

The members of this expert panel have completed conflict-of-interest statements. Disclosures do not suggest bias but provide readers with information relevant to the evaluation of the contents of these recommendations.

Commercial Support

This module was supported by Grant Number 5U58DP003936 funded by the CDC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Department of Health and Human Services.